Genflow Biosciences (FRA:WQ5) Market Cap : €11.79 Mil (As of Jun. 23, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Genflow Biosciences's share price for the quarter that ended in Dec. 2023 was €0.0155. Genflow Biosciences's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 292.51 Mil. Therefore, Genflow Biosciences's market cap for the quarter that ended in Dec. 2023 was €4.53 Mil.

Genflow Biosciences's quarterly market cap declined from Dec. 2022 (€7.61 Mil) to Jun. 2023 (€7.46 Mil) and declined from Jun. 2023 (€7.46 Mil) to Dec. 2023 (€4.53 Mil).

Genflow Biosciences's annual market cap increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€7.61 Mil) but then declined from Dec. 2022 (€7.61 Mil) to Dec. 2023 (€4.53 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Genflow Biosciences's Enterprise Value for Today is €10.98 Mil.

Genflow Biosciences Market Cap Historical Data

The historical data trend for Genflow Biosciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Market Cap Chart

Genflow Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Market Cap

7.61

4.53

Genflow Biosciences Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial			-	8.48	7.61	7.46	4.53

Competitive Comparison of Genflow Biosciences's Market Cap

For the Biotechnology subindustry, Genflow Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genflow Biosciences's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's Market Cap distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's Market Cap falls into.

Genflow Biosciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Genflow Biosciences's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	€0.0155	*	292.507
	=	€4.53

Genflow Biosciences's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	€0.0155	*	292.507
	=	€4.53

Genflow Biosciences (FRA:WQ5) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Genflow Biosciences Market Cap Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences (FRA:WQ5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (FRA:WQ5) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

GENF:UK

Address

6 Heddon Street, London, GBR, W1B 4BT

Website

https://www.genflowbio.com

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences (FRA:WQ5) Headlines

No Headlines